Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00211536 · ClinicalTrials.gov registry record · Phase 3
Study Comparing Effectiveness of Intraperitoneal Insulin Administration to Subcutaneous Insulin Administration
A Phase 3 study, sponsored by Medtronic MiniMed.
- Completed
- Registry status
- Phase 3
- Development phase
- 107
- Enrollment target
NCT00211536: Completed Phase 3 study, sponsored by Medtronic MiniMed.
NCT00211536 is a Phase 3 study that has completed, run by Medtronic MiniMed. The registered enrollment target is 107 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00211536, a Phase 3 study, has completed, sponsored by Medtronic MiniMed.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 107 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effectiveness of insulin delivered in the peritoneum (abdomen)by an implantable pump in Type 1 diabetics.
Primary Outcome
To determine whether Intra Peritoneal insulin delivery via MIP results in glycemic control that is equal to or superior (i.e. not inferior to) control with SC therapy (Ho : μ (IP) -μ (SC) ≥ 0.50% A1C), a repeated measures analysis of variance, adjusting for baseline A1C using SAS Proc Mixed was used to compare average A1C trends over time between the two treatment groups (19). Type 3 Least Square (LS) means for each group were assessed. The Estimate statement within SAS proc mixed was used to es
Interventions
- DRUG Medtronic MiniMed Implantable Pump Human Recombinant Insulin
- DEVICE Medtronic MiniMed Implantable Pump System
- DRUG Aventis HOE21PH U400
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 107 participants |
| Start Date | 2002-06 |
| Est. Completion | 2008-09 |
| Phase | Phase 3 |
What the finished NCT00211536 record still lists
NCT00211536 is an interventional study that assigns participants to a tested intervention. The registered 107 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (86% lower).
The record links to 0 conditions, and to 3 interventions - of which Medtronic MiniMed Implantable Pump Human Recombinant Insulin is the first listed.
NCT00211536 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00211536 about?
NCT00211536 is a clinical study titled "Study Comparing Effectiveness of Intraperitoneal Insulin Administration to Subcutaneous Insulin Administration". The purpose of this study is to evaluate the effectiveness of insulin delivered in the peritoneum (abdomen)by an implantable pump in Type 1 diabetics.
What is the current status of trial NCT00211536?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 107 participants. The study started on 2002-06. Estimated completion is 2008-09.
What interventions are being tested in trial NCT00211536?
The interventions under investigation include: Medtronic MiniMed Implantable Pump Human Recombinant Insulin (DRUG), Medtronic MiniMed Implantable Pump System (DEVICE), Aventis HOE21PH U400 (DRUG).
Who is sponsoring clinical trial NCT00211536?
This trial is sponsored by Medtronic MiniMed, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00211536's enrollment target sits among peer trials
107 1666th of 2000 higher than 335 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05491668 · 107 participants
Physiological Assessment of Severe Coronary Stenosis for Informing Planned PCI
- NCT06041594 · 107 participants · NA
Treating Pulmonary Embolism With Laguna Thrombectomy System (TRUST)
- NCT06081426 · 107 participants · NA
Examining Neurobiological Mechanisms Underlying the Therapeutic Effect of the Ketogenic Diet in Bipolar Disorder (BD)
- NCT06527599 · 107 participants · NA
Screening in Trauma for Opioid Misuse Prevention - an Adaptive Intervention
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia